This research investigated a cardiometabolic model of heart failure with preserved ejection fraction (HFpEF) combining metabolic stress and chronic mineralocorticoid excess. The study aimed to characterize integrated cardiac, vascular, and pulmonary phenotypes.
Key Clinical Findings
Aldosterone-treated mice developed cardiac hypertrophy and pulmonary congestion despite maintaining a preserved left ventricular ejection fraction (LV). Diastolic dysfunction, left atrial remodeling with increased stiffness, and impaired global longitudinal LV strain were observed. Pulmonary hypertension with right ventricular dysfunction was evidenced, alongside elevated right ventricular systolic pressure relative to estimated mean pulmonary artery pressure.
Model Significance
Endothelium-dependent relaxation was impaired in aortae from untreated mice, and this impairment was exacerbated by aldosterone, while endothelium-independent relaxation remained largely unaffected. The model replicated key features of cardiometabolic HFpEF across the cardiac-vascular-pulmonary axis. It provides a translational platform for studying endothelial and ventricular-vascular dysfunction. The model’s preservation of endogenous endothelial nitric oxide signaling offers a means to investigate vascular and cardiopulmonary mechanisms in this condition.